The Latest Breaking News on Pharma

Six drugs from six pharma firms have fuelled a tussle between the Centre and the Delhi government, with both sides trying to blame each other for substandard medicines making their way to the capital’s government hospitals. 

Group will tackle potential restrictions to items such as medicine amid geopolitical and climate threats

Government urged to act as experts sound the alarm on nitazenes, with 54 deaths in past six months likely ‘tip of the iceberg’

There's more than Eylea to like about Regeneron Pharmaceuticals right now, an analyst said Friday as REGN stock touched another record high.

There's a revolution in immunology that could completely shift a paradigm biotech stocks. And Big Pharma is paying billions to get in.

After a better-than-expected 2023, New England states will see only modest employment growth in 2024.

The need for innovative healthcare solutions, personalized medicines and treatments, and the use of advanced technologies will propel the biotech industry forward. Amid this backdrop, let’s explore the investment potential of biotech stocks TG Therapeutics (TGTX), Galapagos (GLPG), BioMarin Pharmaceutical (BMRN), and United Therapeutics (UTHR).

Bayer remains undeterred by setbacks as they forge ahead with plans to expand in the US market, showing resilience and determination in the face of challenges.

As biotech stocks boom on a strong 2024 outlook following a rough two years, the XBI ETF launches a fresh breakout.